SGX-listed glove makers nosedive on vaccine news, profit-taking
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
SHARES of the trio of Singapore-listed glove names - Top Glove, Riverstone Holdings and UG Healthcare - skidded on Wednesday, shedding their gains from recent weeks, following news about Covid-19 vaccines in Russia, Singapore and the United States.
On Tuesday night, pharmaceutical firm Arcturus Therapeutics announced that Singapore's first volunteers have been dosed with a Covid-19 vaccine by Arcturus and Duke-NUS Medical School. Separately, Russia has approved its new vaccine against the novel coronavirus, while the US will buy 100 million doses of drugmaker Moderna's potential vaccine for some US$1.5 billion.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
